COVID-19 Research Highlights Need for Targeted Public Health Strategies in Taiwan

Strategic Insights -

Researchers at Taipei Medical University have conducted a retrospective cohort study to identify determinants significantly influencing severe COVID-19 infection and mortality among the general population in Taiwan. The study analyzed data from 96,489 confirmed COVID-19 cases, with 44,996 (46.6%) classified as high-risk patients. The findings suggest that male patients had significantly higher risks of ventilator use compared to females. These results emphasize the need for targeted public health strategies for high-risk groups.

Key Takeaways:

  • The study analyzed data from 96,489 confirmed COVID-19 cases in Taiwan, with 44,996 (46.6%) classified as high-risk patients.
  • Male patients had significantly higher risks of ventilator use compared to females, with an odds ratio of 1.245 (95% CI = 1.147-1.352, P < 0.001).
  • The study highlights the need for targeted public health strategies for high-risk groups.
  • The research concluded that understanding the factors contributing to severe outcomes is critical for public health strategies.
  • The study used data extracted from the Taipei Medical University Clinical Research Database from January 1, 2022, to December 31, 2022.
  • The primary outcomes included hospitalization, ventilator use, intubation, and mortality.
  • The study performed logistic regression analyses to explore the association of various factors, including demographic characteristics, body mass index (BMI), Charlson Comorbidity Index score, and multiple comorbidities.

Statistics:

  • 96,489 confirmed COVID-19 cases were analyzed in the study.
  • 44,996 (46.6%) of the confirmed cases were classified as high-risk patients.
  • Male patients had a significantly higher risk of ventilator use compared to females, with an odds ratio of 1.245 (95% CI = 1.147-1.352, P < 0.001).
  • The study used data extracted from the Taipei Medical University Clinical Research Database from January 1, 2022, to December 31, 2022.

Sources:

  • Health risk assessment for severe COVID-19 in Taiwan: a multi-centre electronic health record study. Journal of Global Health, 2025;15:04236.
  • Taipei Medical University.
  • Whitney Burton, International Ph.D. Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan.
  • Int Soc Global Health, Caledonian Exchange, 19A Canning St, Edinburgh, Lothian, England.
  • NewsRx LLC, 2025.